ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,749, issued on April 14, was assigned to ZP SPV 3 K/S (Soborg, Denmark). "Compstatin analogues and their medical uses" was invented by Ann... Read More
ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,750, issued on April 14, was assigned to Xiamen University (Xiamen, China) and Xiamen Innovax Biotech Co. Ltd. (Xiamen, China). "Methods f... Read More
ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,751, issued on April 14. "Modified S2 subunit of the coronavirus spike protein" was invented by Annika Kraemer-Kuehl (Seesen, Germany) and... Read More
ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,752, issued on April 14, was assigned to The University of North Carolina at Chapel Hill (Chapel Hill, N.C.). "Methods and compositions fo... Read More
ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,754, issued on April 14, was assigned to Spiber Inc. (Yamagata, Japan). "Protein fiber production method" was invented by Yunosuke Abe (Ts... Read More
ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,756, issued on April 14, was assigned to TREFOIL THERAPEUTICS INC. (San Diego). "Recombinant modified fibroblast growth factors and therap... Read More
ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,757, issued on April 14, was assigned to Bioniz Therapeutics Inc. (La Jolla, Calif.). "Peptides inhibiting gamma-c-cytokine activity and m... Read More
ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,758, issued on April 14, was assigned to Amgen Inc. (Thousand Oaks, Calif.). "Interleukin-2 muteins for the expansion of T-regulatory cell... Read More
ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,759, issued on April 14, was assigned to ENZENE BIOSCIENCES Ltd. (Pune Maharashtra, India). "Process of preparation of glucagon-like pepti... Read More
ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,760, issued on April 14, was assigned to The General Hospital Corp. (Boston). "Chimeric antigen receptors targeting CD79B and CD19" was in... Read More